These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21717460)
1. Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer. Arima Y; Hayashi N; Hayashi H; Sasaki M; Kai K; Sugihara E; Abe E; Yoshida A; Mikami S; Nakamura S; Saya H Int J Cancer; 2012 Jun; 130(11):2568-79. PubMed ID: 21717460 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells. Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653 [TBL] [Abstract][Full Text] [Related]
3. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells. Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855 [TBL] [Abstract][Full Text] [Related]
4. Cell fate determination factor Dachshund reprograms breast cancer stem cell function. Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839 [TBL] [Abstract][Full Text] [Related]
5. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells]. Yan ZY; Sun XC Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669 [No Abstract] [Full Text] [Related]
6. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro]. Peng L; Li FX; Shao WF; Xiong JB Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739 [TBL] [Abstract][Full Text] [Related]
7. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Nishi M; Sakai Y; Akutsu H; Nagashima Y; Quinn G; Masui S; Kimura H; Perrem K; Umezawa A; Yamamoto N; Lee SW; Ryo A Oncogene; 2014 Jan; 33(5):643-52. PubMed ID: 23318426 [TBL] [Abstract][Full Text] [Related]
8. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Fillmore CM; Kuperwasser C Breast Cancer Res; 2008; 10(2):R25. PubMed ID: 18366788 [TBL] [Abstract][Full Text] [Related]
9. STAT3 as a promising chemoresistance biomarker associated with the CD44 Moreira MP; da Conceição Braga L; Cassali GD; Silva LM Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the stemness potency of Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948 [TBL] [Abstract][Full Text] [Related]
11. Cancer stem-like properties of hormonal therapy-resistant breast cancer cells. Uchiumi K; Tsuboi K; Sato N; Ito T; Hirakawa H; Niwa T; Yamaguchi Y; Hayashi SI Breast Cancer; 2019 Jul; 26(4):459-470. PubMed ID: 30610551 [TBL] [Abstract][Full Text] [Related]
12. Expression of p16 and pRB in invasive breast cancer. Shin E; Jung WH; Koo JS Int J Clin Exp Pathol; 2015; 8(7):8209-17. PubMed ID: 26339389 [TBL] [Abstract][Full Text] [Related]
13. [Methylation and expression of gene p16INK4a and RB in breast carcinoma]. Zhao YF; Shen SP; Jiang JY; Geng H; Guo JG; Xie LP Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):377-81. PubMed ID: 21055153 [TBL] [Abstract][Full Text] [Related]
14. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties. Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163 [TBL] [Abstract][Full Text] [Related]
15. Metalloprotease-dependent activation of EGFR modulates CD44 Wise R; Zolkiewska A Breast Cancer Res Treat; 2017 Nov; 166(2):421-433. PubMed ID: 28791489 [TBL] [Abstract][Full Text] [Related]
16. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer. Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162 [TBL] [Abstract][Full Text] [Related]
17. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells. Alberti L; Losi L; Leyvraz S; Benhattar J PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996 [TBL] [Abstract][Full Text] [Related]